Recent discussions on X about Blend Labs (BLND) have centered around the company's latest financial performance and strategic moves, sparking a mix of curiosity and concern among investors. Posts highlight the company's fourth consecutive quarter of growth, with revenue climbing to $31.5 million in Q2, a 10% increase year-over-year. However, some users have pointed out ongoing risks tied to the company's reliance on mortgage volumes for profitability.
Additionally, there’s buzz around insider activity, with significant stock sales by executives drawing attention, alongside speculation about a potential pivot toward an AI-driven narrative to boost sales in the banking sector. The involvement of a major shareholder increasing their stake has also fueled debates about the future direction of Blend Labs. These conversations reflect a broader interest in how the company navigates a challenging market while eyeing technological innovation.
Note: This discussion summary was generated from an AI condensation of post data.
Blend Labs Insider Trading Activity
Blend Labs insiders have traded $BLND stock on the open market 19 times in the past 6 months. Of those trades, 4 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $BLND stock by insiders over the last 6 months:
- INVESTMENTS, L.P. HAVELI has made 4 purchases buying 3,123,242 shares for an estimated $9,565,535 and 0 sales.
- NIMA GHAMSARI (HEAD OF BLEND) has made 0 purchases and 3 sales selling 431,736 shares for an estimated $1,309,734.
- BRIAN KNEAFSEY (Head of Revenue) has made 0 purchases and 7 sales selling 175,000 shares for an estimated $575,145.
- WINNIE LING (HEAD OF LEGAL AND PEOPLE) has made 0 purchases and 5 sales selling 30,000 shares for an estimated $110,142.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Blend Labs Hedge Fund Activity
We have seen 97 institutional investors add shares of Blend Labs stock to their portfolio, and 122 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- EDGEPOINT INVESTMENT GROUP INC. removed 3,318,924 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $10,952,449
- DRIEHAUS CAPITAL MANAGEMENT LLC removed 2,434,596 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $8,155,896
- J. GOLDMAN & CO LP added 1,891,941 shares (+37.4%) to their portfolio in Q2 2025, for an estimated $6,243,405
- MARSHALL WACE, LLP added 1,543,220 shares (+157.6%) to their portfolio in Q2 2025, for an estimated $5,092,626
- BLACKROCK, INC. removed 1,400,249 shares (-7.7%) from their portfolio in Q2 2025, for an estimated $4,620,821
- G2 INVESTMENT PARTNERS MANAGEMENT LLC removed 1,394,133 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $4,670,345
- RENAISSANCE TECHNOLOGIES LLC added 1,170,200 shares (+inf%) to their portfolio in Q2 2025, for an estimated $3,861,660
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Blend Labs Analyst Ratings
Wall Street analysts have issued reports on $BLND in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JMP Securities issued a "Market Outperform" rating on 05/28/2025
- Goldman Sachs issued a "Buy" rating on 05/12/2025
- Canaccord Genuity issued a "Buy" rating on 05/12/2025
- Wells Fargo issued a "Overweight" rating on 04/22/2025
- Citizens Capital Markets issued a "Market Outperform" rating on 03/13/2025
To track analyst ratings and price targets for Blend Labs, check out Quiver Quantitative's $BLND forecast page.
Blend Labs Price Targets
Multiple analysts have issued price targets for $BLND recently. We have seen 7 analysts offer price targets for $BLND in the last 6 months, with a median target of $5.0.
Here are some recent targets:
- Karl Keirstead from UBS set a target price of $3.5 on 08/08/2025
- Ryan Tomasello from Keefe, Bruyette & Woods set a target price of $3.75 on 08/08/2025
- Aaron Kimson from JMP Securities set a target price of $7.0 on 05/28/2025
- Michael Ng from Goldman Sachs set a target price of $4.8 on 05/12/2025
- Joseph Vafi from Canaccord Genuity set a target price of $5.25 on 05/12/2025
- Michael Turrin from Wells Fargo set a target price of $5.0 on 04/22/2025
- Aaron Kimson from Citizens Capital Markets set a target price of $7.0 on 03/13/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
